BIOG vs. IEM, RICA, CGT, SAIN, MUT, JEO, APEO, BLU, ESCT, and SDP
Should you be buying The Biotech Growth Trust stock or one of its competitors? The main competitors of The Biotech Growth Trust include Impax Environmental Markets (IEM), Ruffer Investment (RICA), Capital Gearing (CGT), Scottish American Investment (SAIN), Murray Income Trust (MUT), European Opportunities Trust (JEO), abrdn Private Equity Opportunities (APEO), Blue Star Capital (BLU), The European Smaller Companies Trust (ESCT), and Schroder Investment Trust - Schroder AsiaPacific Fund (SDP). These companies are all part of the "asset management" industry.
The Biotech Growth Trust vs. Its Competitors
Impax Environmental Markets (LON:IEM) and The Biotech Growth Trust (LON:BIOG) are both small-cap financial services companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, profitability, valuation, institutional ownership, dividends, risk and earnings.
In the previous week, Impax Environmental Markets had 2 more articles in the media than The Biotech Growth Trust. MarketBeat recorded 2 mentions for Impax Environmental Markets and 0 mentions for The Biotech Growth Trust. The Biotech Growth Trust's average media sentiment score of 0.00 beat Impax Environmental Markets' score of -0.48 indicating that The Biotech Growth Trust is being referred to more favorably in the news media.
Impax Environmental Markets has a beta of 0.79, indicating that its share price is 21% less volatile than the S&P 500. Comparatively, The Biotech Growth Trust has a beta of 0.5, indicating that its share price is 50% less volatile than the S&P 500.
The Biotech Growth Trust has higher revenue and earnings than Impax Environmental Markets. Impax Environmental Markets is trading at a lower price-to-earnings ratio than The Biotech Growth Trust, indicating that it is currently the more affordable of the two stocks.
The Biotech Growth Trust has a net margin of 95.33% compared to Impax Environmental Markets' net margin of -691.26%. The Biotech Growth Trust's return on equity of 26.96% beat Impax Environmental Markets' return on equity.
41.2% of Impax Environmental Markets shares are held by institutional investors. Comparatively, 28.6% of The Biotech Growth Trust shares are held by institutional investors. 2.8% of Impax Environmental Markets shares are held by company insiders. Comparatively, 0.7% of The Biotech Growth Trust shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Summary
The Biotech Growth Trust beats Impax Environmental Markets on 8 of the 13 factors compared between the two stocks.
Get The Biotech Growth Trust News Delivered to You Automatically
Sign up to receive the latest news and ratings for BIOG and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
The Biotech Growth Trust Competitors List
Related Companies and Tools
This page (LON:BIOG) was last updated on 8/10/2025 by MarketBeat.com Staff
Free BIOG Stock Alerts